Mode
Text Size
Log in / Sign up

Deep learning segmentation with CT elasticity features predicts right recurrent laryngeal nerve metastasis in esophageal cancer.

Deep learning segmentation with CT elasticity features predicts right recurrent laryngeal nerve meta…
Photo by Logan Voss / Unsplash
Key Takeaway
Consider this deep learning radiomics model as a potential preoperative tool for predicting nerve metastasis in esophageal cancer, pending validation.

This retrospective cohort study included 415 patients diagnosed with esophageal squamous cell carcinoma. The study evaluated a deep learning-based automatic segmentation model (nnU-Net) combined with computed tomography-derived differential elasticity map (DEM) radiomic features for preoperative prediction of right recurrent laryngeal nerve lymph node metastasis, compared to conventional radiomics and metastatic versus non-metastatic groups.

The automatic segmentation model achieved a Dice coefficient of 0.898 ± 0.024. For diagnostic performance, the entropy feature showed the highest performance with an AUC of 0.814, sensitivity of 0.895, and specificity of 0.709. Fractal dimension-related features were significantly elevated in the metastatic group (all P < 0.001).

Clinical utility was assessed via decision curve analysis, which showed positive net benefits across threshold probabilities from 10% to 70%. Safety and tolerability data were not reported.

Key limitations include the retrospective design and lack of reported follow-up duration or external validation. The study provides a promising tool for preoperative decision support and personalized treatment planning, but these results are observational and require prospective confirmation before clinical adoption.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveAccurate preoperative prediction of lymph node metastasis adjacent to the right recurrent laryngeal nerve (RLN) in esophageal squamous cell carcinoma (ESCC) is crucial for treatment planning. This study aimed to develop and validate an imaging approach that integrates deep learning-based automatic segmentation (nnU-Net) with computed tomography (CT)-derived differential elasticity map (DEM) to predict RLN lymph node metastasis in ESCC.MethodsThis retrospective study included 415 patients diagnosed with ESCC. An automatic segmentation model was trained using the nnU-Net framework to delineate lymph nodes near the right RLN. Three-dimensional CT elasticity images were generated from segmented CT voxels, from which radiomic features, including first-order entropy and multi-scale fractal dimensions, were extracted. Statistically significant features were selected using statistical tests and area under the curve (AUC) analyses, and their diagnostic efficacy, probability calibration, and clinical decision-making value were further evaluated in a validation cohort.ResultsThe automatic segmentation model achieved a Dice coefficient of 0.898 ± 0.024. Five DEM-derived radiomic features were ultimately selected: one first-order entropy feature (E_original_firstorder_Entropy) and four fractal dimension-related features. The entropy feature exhibited the highest diagnostic performance (AUC = 0.814, sensitivity = 0.895, specificity = 0.709), and fractal dimension-related features were significantly elevated (all P < 0.001) in the metastatic group, indicating increased textural complexity and multi-scale irregularity. Calibration curves demonstrated the robustness of entropy-based probability estimation. Decision curve analysis confirmed the clinical utility of these features, showing positive net benefits across a wide range of threshold probabilities (10%–70%).ConclusionThe proposed automated workflow, combining nnU-Net segmentation and DEM-based radiomics, enables accurate and non-invasive prediction of right RLN lymph node metastasis in ESCC. First-order entropy and fractal dimension features offer valuable complementary information beyond conventional radiomics, providing a promising tool for preoperative decision support and personalized treatment planning.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.